Catequentinib/eribulin/toripalimabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71801-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：108 / 108

相关论文

共 50 条

[1] Lenvatinib/toripalimabLack of efficacy: case report
Reactions Weekly, 2023, 1972 (1) : 201 - 201
[2] Afatinib/toripalimabLack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 25 - 25
[3] Catequentinib/nivolumabLack of efficacy: case report
Reactions Weekly, 2022, 1910 (1) : 129 - 129
[4] Catequentinib/temozolomideLack of efficacy: case report
Reactions Weekly, 2025, 2049 (1) : 96 - 96
[5] Catequentinib/temozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1952 (1) : 118 - 118
[6] Catequentinib/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1933 (1) : 138 - 138
[7] Catequentinib/gefitinibLack of efficacy: case report
Reactions Weekly, 2022, 1934 (1) : 123 - 123
[8] Catequentinib/osimertinibLack of efficacy: case report
Reactions Weekly, 2023, 1970 (1) : 88 - 88
[9] Catequentinib/nivolumabLack of efficacy: case report
Reactions Weekly, 2023, 1977 (1) : 92 - 92
[10] Catequentinib/osimertinibLack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 150 - 150

← 1 2 3 4 5 →